FDA Inspection
Bausch Health Companies Inc.Bausch Health Companies Inc. – FDA Inspection, Sep 20, 2013
Record Details
This FDA Inspection record concerns Bausch Health Companies Inc., with an inspection on September 20, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bausch Health Companies Inc.
- Inspection Date
- September 20, 2013
- Product Type
- Drugs
View Company Profile
ID · 35e3c23a-b623-4d55-9ca5-0230b48e0f41
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 850664
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bausch Health Companies Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| January 19, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 29, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 19, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 26, 2019 | VAI | Office of Inspections and Investigations | New Drug Evaluation |
| February 17, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bausch Health Companies Inc.
- FDA Inspection 1229765 - 2024-01-19
- FDA Inspection 1190487 - 2022-09-29
- FDA Inspection 1108379 - 2019-09-19
- FDA Inspection 1089615 - 2019-04-26
- FDA Inspection 1007199 - 2017-02-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.